Grail, Inc. (NASDAQ:GRAL - Get Free Report) CFO Aaron Freidin sold 1,816 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $56,659.20. Following the sale, the chief financial officer now directly owns 335,170 shares in the company, valued at $10,457,304. This represents a 0.54 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Grail Price Performance
NASDAQ GRAL traded up $2.82 during trading hours on Friday, hitting $29.74. 1,412,295 shares of the company were exchanged, compared to its average volume of 1,227,880. The company has a 50 day moving average of $31.81 and a two-hundred day moving average of $21.34. Grail, Inc. has a 52-week low of $12.33 and a 52-week high of $63.99.
Grail (NASDAQ:GRAL - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping analysts' consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to analysts' expectations of $35.33 million. Analysts forecast that Grail, Inc. will post -15.15 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Morgan Stanley initiated coverage on shares of Grail in a report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 target price on the stock.
View Our Latest Analysis on Grail
Institutional Investors Weigh In On Grail
Institutional investors have recently modified their holdings of the company. FNY Investment Advisers LLC acquired a new stake in Grail in the fourth quarter valued at $26,000. State of Tennessee Department of Treasury acquired a new stake in shares of Grail during the 4th quarter worth about $28,000. Lindbrook Capital LLC purchased a new stake in Grail during the fourth quarter worth approximately $28,000. Sterling Capital Management LLC acquired a new position in Grail in the fourth quarter valued at approximately $29,000. Finally, Wellington Shields Capital Management LLC acquired a new position in Grail in the fourth quarter valued at approximately $33,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
See Also
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
